The health system expanded testing to ER patients in April.
“It’s a population that has a lot of unmet needs,” said Eric Huckins, a pharmacy supervisor at SSM Health. “Most patients aren’t going to show symptoms until it’s too late, where they’re going to have an opportunistic infection that’s going to kill them or debilitate them. Now, with this screening program, we can identify them, link them into care and get them treated.”
Madison, Wis.-based UnityPoint Health-Meriter offers the tests in the ER to patients with emergent risks, including those who have been sexually assaulted, spokesperson Leah Huibregtse told the Wisconsin State Journal.
Using a $200,000 grant from Gilead Sciences, SSM Health hired two coordinators for the testing program.
Physicians or nurses offer the tests to ER patients in targeted age groups, and patients can refuse. Patients receive results within a few days, and can be referred for treatment if they test positive.
Fewer than 5 percent of eligible patients have agreed to testing. The goal is to reach 20 percent or more. Mr. Huckins attributes the low percentage to stigma, and hopes public education can help raise this number.
More articles on clinical leadership and infection control:
MRSA nasal screening can effectively identify MRSA pneumonia
Parent skin-to-skin contact with premature babies may up NICU staph infections
Most grocery store meat contains antibiotic-resistant bacteria: 4 things to know
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.